Contact us
Menu
Contact us

Feldan News

Feldan Therapeutics

Recent Posts by Feldan Therapeutics:

on Apr 14,2021

Read more on pages 54 to 57: BIOTECanada Insights sping 2021 …

Read Story

on Apr 7,2021

Congratulations to the team at NIH Common Fund’s Somatic Cell Genome Editing (SCGE) program for publishing their work in the journal Nature. Feldan is honoured to be part of this initiative alongside its long-standing collaborator, Dr. Paul McCray of the University of Iowa. https://www.nature.com/articles/s41586-021-03191-1 About the collaboration between Dr. McCray and Feldan Therapeutics: The lungs, …

Read Story

on Feb 9,2021

Québec, Canada, February 9, 2021 – Feldan Therapeutics, a biotechnology company that develops therapeutics based on the intracellular delivery of proteins and peptides, announces the appointment of Dr. David J …

Read Story

on Jan 14,2021

Quebec City, Canada, January 14, 2021 – Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on the intracellular delivery of proteins and peptides, announces the creation …

Read Story